Novita (Drug Discovery) Overview
- Year Founded
-
2010
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
2ndary - Private
- Investors
-
3
Novita (Drug Discovery) General Information
Description
Operator of a biopharmaceutical company intended to develop drugs to prevent and treat cancer metastasis and boost anti-cancer immune responses. The company manufactures drugs using its proprietary fascin inhibitor technology and focuses on patients with metastatic breast cancer, enabling healthcare providers to cure their patients optimally and improve their quality of life.
Contact Information
Website
www.novita-pharm.comCorporate Office
- 445 Park Avenue
- Suite 19A
- New York, NY 10022
- United States
Corporate Office
- 445 Park Avenue
- Suite 19A
- New York, NY 10022
- United States
Novita (Drug Discovery) Timeline
Novita (Drug Discovery) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Secondary Transaction - Private | 01-Dec-2023 | 000.00 | Completed | Clinical Trials - Phase 2 | ||
| 3. Later Stage VC (Series A) | 13-Dec-2021 | 000.00 | 000.00 | 00000 | Completed | Clinical Trials - Phase 2 |
| 2. Early Stage VC (Series A) | 28-Feb-2017 | $6.46M | $8.11M | 00000 | Completed | Pre-Clinical Trials |
| 1. Seed Round | 04-Jan-2011 | $1.65M | $1.65M | Completed | Pre-Clinical Trials |
Novita (Drug Discovery) Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 0,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Novita (Drug Discovery) Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Novita (Drug Discovery) Patents
Novita (Drug Discovery) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3084512-A1 | Co-therapies including a metastasis inhibitor | Pending | 22-Nov-2017 | 0000000000 | |
| US-20200352911-A1 | Co-therapies including a metastasis inhibitor | Active | 22-Nov-2017 | 0000000000 | |
| EP-3713570-A1 | Co-therapies including a metastasis inhibitor | Pending | 22-Nov-2017 | 0000000000 | |
| EP-3713570-A4 | Co-therapies including a metastasis inhibitor | Pending | 22-Nov-2017 | 0000000000 | 0 |
| US-20230310378-A1 | Co-therapies including a metastasis inhibitor | Pending | 22-Nov-2017 | A61K31/4162 |
Novita (Drug Discovery) Executive Team (7)
| Name | Title | Board Seat |
|---|---|---|
| Jillian Zhang | Co-Founder, President, Chief Scientific Officer & Board Member | |
| Christy Shue | Chief Financial Officer & Investor Relations Officer | |
| Xin-Yun Huang | Co-Founder & Chairman | |
| Cheryl Brinkman | Vice President of Clinical Operations | |
| Jose Jimeno Ph.D | Chief Medical Officer |
Novita (Drug Discovery) Board Members (7)
| Name | Representing | Role | Since |
|---|---|---|---|
| Jackson Tai | Self | Board Member | 000 0000 |
| Jiangtao Yu | Self | Board Member | 000 0000 |
| Jillian Zhang | Novita (Drug Discovery) | Co-Founder, President, Chief Scientific Officer & Board Member | 000 0000 |
| Jonathan Zhu | Self | Board Member | 000 0000 |
| Xin-Yun Huang | Novita (Drug Discovery) | Co-Founder & Chairman | 000 0000 |
Novita (Drug Discovery) Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Novita (Drug Discovery) Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cloudstone Capital | Venture Capital | Minority | 000 0000 | 000000 0 |
| Gaorong Capital | Venture Capital | Minority | 000 0000 | 000000 0 |
| Lifespan Investments | Venture Capital | Minority | 000 0000 | 000000 0 |
Novita (Drug Discovery) FAQs
-
When was Novita (Drug Discovery) founded?
Novita (Drug Discovery) was founded in 2010.
-
Who is the founder of Novita (Drug Discovery)?
Jillian Zhang and Xin-Yun Huang are the founders of Novita (Drug Discovery).
-
Where is Novita (Drug Discovery) headquartered?
Novita (Drug Discovery) is headquartered in New York, NY.
-
What is the size of Novita (Drug Discovery)?
Novita (Drug Discovery) has 6 total employees.
-
What industry is Novita (Drug Discovery) in?
Novita (Drug Discovery)’s primary industry is Drug Discovery.
-
Is Novita (Drug Discovery) a private or public company?
Novita (Drug Discovery) is a Private company.
-
What is Novita (Drug Discovery)’s current revenue?
The current revenue for Novita (Drug Discovery) is 000000.
-
How much funding has Novita (Drug Discovery) raised over time?
Novita (Drug Discovery) has raised $49.6M.
-
Who are Novita (Drug Discovery)’s investors?
Cloudstone Capital, Gaorong Capital, and Lifespan Investments have invested in Novita (Drug Discovery).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
